Skip to main content
. 2013 Aug 30;2013(8):CD001245. doi: 10.1002/14651858.CD001245.pub2

1.3. Analysis.

Comparison 1 Antifibrinolytic treatment versus control treatment with or without placebo, Outcome 3 Rebleeding reported at end of follow up: open versus blind studies.